Omega Fund V, L.P. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$26.72M
Insider Sells Quantity
15
Insider Sells Sum
$61.36M

Insider Activity of Omega Fund V, L.P.

Biography of Omega Fund V, L.P.

No biography is available at this moment.

2021-12-15SaleNuvation Bio Inc.
NUVB
10 percent owner
500,000
0.2537%
$10.07$5.04M-64.26%
2021-12-07SaleNuvation Bio Inc.
NUVB
10 percent owner
1.4M
0.726%
$9.80$13.72M-61.57%
2021-11-23SaleNuvation Bio Inc.
NUVB
10 percent owner
36
<0.0001%
$9.75$351-57.14%
2021-11-22SaleNuvation Bio Inc.
NUVB
10 percent owner
295,000
0.1492%
$9.76$2.88M-58.82%
2021-11-03SaleNuvation Bio Inc.
NUVB
10 percent owner
2M
0.9862%
$9.25$18.5M-51.95%
2021-10-29SaleNuvation Bio Inc.
NUVB
10 percent owner
45,000
0.023%
$9.27$417,150-48.31%
2021-10-28SaleNuvation Bio Inc.
NUVB
10 percent owner
1.01M
0.5189%
$9.60$9.74M-50%
2019-09-20SaleGossamer Bio, Inc.
GOSS
10 percent owner
367,214
0.3016%
$10.98$4.03M-37.71%
2019-09-18SaleGossamer Bio, Inc.
GOSS
10 percent owner
91,200
0.076%
$10.94$997,637-36.53%
2019-09-17SaleGossamer Bio, Inc.
GOSS
10 percent owner
46,800
0.0387%
$10.81$505,791-36.23%
2019-09-16SaleGossamer Bio, Inc.
GOSS
10 percent owner
26,426
0.0219%
$10.76$284,331-35.41%
2019-09-11SaleGossamer Bio, Inc.
GOSS
10 percent owner
160,806
0.2646%
$21.31$3.43M-34.94%
2019-09-10SaleGossamer Bio, Inc.
GOSS
10 percent owner
64,746
0.1072%
$21.00$1.36M-33.48%
2019-09-06SaleGossamer Bio, Inc.
GOSS
10 percent owner
17,400
0.0151%
$10.75$187,103-31.7%
2019-09-05SaleGossamer Bio, Inc.
GOSS
10 percent owner
25,408
0.0217%
$10.80$274,434-33%
2019-05-09PurchaseTrevi Therapeutics, Inc.
TRVI
10 percent owner
962,000
6.6593%
$10.00$9.62M-42.9%
Total: 16
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.